医学
帕金森病
疾病
内科学
人口
风险因素
家族史
运动症状
物理疗法
环境卫生
作者
Daniele Belvisi,Roberta Pellicciari,A Fabbrini,Matteo Costanzo,Gaia Ressa,Sara Pietracupa,Maria De Lucia,Nicola Modugno,Francesca Magrinelli,Carlo Dallocchio,Tommaso Ercoli,Alessandra Nicoletti,Mario Zappia,Paolo Solla,Matteo Bologna,Giovanni Fabbrini,Michèle Tinazzi,Antonella Conte,Alfredo Berardelli,Giovanni Defazio
标识
DOI:10.1016/j.parkreldis.2022.04.017
摘要
Non-genetic risk factors play a relevant role in Parkinson's disease (PD) development but the relationship between these factors and PD clinical features is unknown.The aim of the present multicenter study was to investigate possible relationship between risk factors and clinical motor and non-motor features in a large sample of PD patients.Six hundred ninety-four patients with PD participated. Patients underwent a clinical evaluation assessing motor symptoms and motor complications as well as non-motor symptoms severity. Information regarding pharmacological treatment was also collected. Risk and protective factors were previously identified in the present population and included coffee consumption, cigarette smoking, and physical activity as protective factors and a family history of PD, dyspepsia, exposure to toxic agents and general anesthesia as risk factors. Multiple regression models were used to investigate the relationship between risk factors and clinical variables.Coffee consumption predicted older age at onset (B: 0.527; CI: 0.195; 0.858) and milder motor symptom severity (B: 1.383; CI: 2.646; -0.121). Non-motor symptom severity was more severe in patients with dyspepsia before PD (B: 13.601; CI 5.019; 22.182) and milder in patients who performed physical activity before PD (B: 11.355; CI: 16.443; -6.266). We found no relationship between risk factors and motor complications, motor subtype and pharmacological treatment.Risk and protective factors of PD development may influence PD clinical features. This finding may represent the first step in the development of new preventive approaches able to delay disease onset and mitigate the extent of clinical manifestations.
科研通智能强力驱动
Strongly Powered by AbleSci AI